Literature DB >> 2730186

Pheochromocytoma. Lateral versus anterior operative approach.

G L Irvin1, L M Fishman, J A Sher, L K Yeung, H Irani.   

Abstract

The possibility of bilateral, extra-adrenal, and malignant tumors has dictated a thorough abdominal exploration through an anterior incision in the management of patients with pheochromocytomas. Careful visualization or palpation of the sites known to harbor secondary tumors is still recommended by many surgeons. The present study contrasts the results and morbidity of the retroperitoneal approach with that of the intraperitoneal operative approach for resection of pheochromocytoma. In the last 14 years, 37 patients had successful total resections of their pheochromocytomas, excluding one patient with metastasis to the liver at the time of surgery who died 10 years after operation. After preoperative localization of their tumors, 17 patients were explored anteriorly and 20 underwent resection using a lateral approach. Thirty-one patients have been followed from 2 to 141 (average 56) months. All patients have either returned to a normotensive state on no medication (27 patients) or, while requiring medication (9 patients), have had normal urinary metanephrine/catecholamine levels, except for the one patient with metatastic disease. There were substantial differences in morbidity rates between the two groups, however. Four patients (20%) had minor postoperative complications, following retroperitoneal resection that included pleural effusion, urinary retention, pulmonary congestion, and fever. Nine patients (53%) had complications when the anterior approach was used, including splenectomy in two, pneumonia, and postoperative fever. Postoperative hospital stay averaged 9.8 days (range, 4 to 21 days) for the anterior group and 6.1 days (range, 4 to 12 days) when a lateral approach was used (p = 0.002). Our data suggest that, with accurate unilateral localization, the flank, retroperitoneal approach for resection of pheochromocytoma can be used successfully with less morbidity.

Entities:  

Mesh:

Year:  1989        PMID: 2730186      PMCID: PMC1494113          DOI: 10.1097/00000658-198906000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  8 in total

1.  Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome.

Authors:  J A van Heerden; G W Sizemore; J A Carney; C S Grant; W H ReMine; S G Sheps
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

2.  Adrenalectomy: anterior or posterior approach?

Authors:  C F Russell; B Hamberger; J A van Heerden; A J Edis; D M Ilstrup
Journal:  Am J Surg       Date:  1982-09       Impact factor: 2.565

3.  Limitations of 131I-MIBG scintigraphy in locating pheochromocytomas.

Authors:  I R Gough; N W Thompson; B Shapiro; J C Sisson
Journal:  Surgery       Date:  1985-07       Impact factor: 3.982

4.  Familial pheochromocytoma.

Authors:  G L Irvin; L M Fishman; J A Sher
Journal:  Surgery       Date:  1983-12       Impact factor: 3.982

5.  Pheochromocytoma: present diagnosis and management.

Authors:  H W Scott; J A Oates; A S Nies; H Burko; D L Page; R K Rhamy
Journal:  Ann Surg       Date:  1976-05       Impact factor: 12.969

6.  Pheochromocytoma: value of computed tomography.

Authors:  T J Welch; P F Sheedy; J A van Heerden; S G Sheps; R R Hattery; D H Stephens
Journal:  Radiology       Date:  1983-08       Impact factor: 11.105

7.  Selective use of retroperitoneal aortic exposure in the emergency treatment of ruptured and symptomatic abdominal aortic aneurysms.

Authors:  B B Chang; P K Paty; D M Shah; R P Leather
Journal:  Am J Surg       Date:  1988-08       Impact factor: 2.565

8.  Pheochromocytoma: current status and changing trends.

Authors:  J A van Heerden; S G Sheps; B Hamberger; P F Sheedy; J G Poston; W H ReMine
Journal:  Surgery       Date:  1982-04       Impact factor: 3.982

  8 in total
  8 in total

1.  The influence of new technologies on laparoscopic adrenalectomy: our personal experience with 91 patients.

Authors:  A Valeri; A Borrelli; L Presenti; M Lucchese; G Manca; P Tonelli; C Bergamini; D Borrelli; M Palli; C Saieva
Journal:  Surg Endosc       Date:  2002-05-07       Impact factor: 4.584

2.  [Minimally invasive adrenalectomy for pheochromocytoma: routine or risk?].

Authors:  I Gockel; A Heintz; W Roth; T Junginger
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

3.  Successful removal of large adrenal pheochromocytoma on the right side with liver mobilization.

Authors:  N Aoyama; I Sasagawa; Y Iijima; H Suzuki; Y Kubota; T Nakada
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

4.  Laparoscopic removal of pheochromocytoma. Why? When? and Who? (reflections on one case report).

Authors:  M Meurisse; J Joris; E Hamoir; B Hubert; C Charlier
Journal:  Surg Endosc       Date:  1995-04       Impact factor: 4.584

5.  Endoscopic adrenalectomy for pheochromocytoma: difference between the transperitoneal and retroperitoneal approaches in terms of the operative course.

Authors:  I Gockel; G Vetter; A Heintz; Th Junginger
Journal:  Surg Endosc       Date:  2005-05-26       Impact factor: 4.584

6.  High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991.

Authors:  C Proye; M Vix; A Goropoulos; P Kerlo; M Lecomte-Houcke
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

7.  Safe retroperitoneal endoscopic resection of pheochromocytomas.

Authors:  Frits J Berends; Erwin Van Der Harst; Giuseppe Giraudo; Türkan Terkivatan; Geert Kazemier; Hajo A Bruining; Wouter W De Herder; H Jaap Bonjer
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

8.  Laparoscopic adrenal surgery.

Authors:  M E Stoker; N Patwardhan; B S Maini
Journal:  Surg Endosc       Date:  1995-04       Impact factor: 4.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.